The global anti-aging market size is expected to reach around US$ 119.6 billion by 2030 from US$ 60.42 billion in 2021 and is expected to grow at an impressive double-digit rate of 7.9% from 2022 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global anti-aging market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 180+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1597
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global anti-aging market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global anti-aging market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Market Scope:
| Report Coverage | Details |
| Market Size by 2030 | USD 119.6 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 7.9% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Report Highlights
- Based on the products, anti-wrinkle segment is estimated to be the most opportunistic segment during the forecast period. This can be attributed to increased awareness of the impact of anti-wrinkle products.
- Based on the demography, the generation X segment dominated the global anti-aging market in 2020 with highest market share. This is mostly due to people’s increasing awareness of their skin’s look and as a result the need to lessen the indications of aging.
Market Dynamics
Drivers
Shift in consumer preferences
The widespread availability of at-home anti-aging equipment for wrinkle reduction, skin rejuvenation, cellulite reduction, and microdermabrasion has led to an increase in customer interest. Furthermore, these products are scientifically advanced and portable. The popularity of at-home anti-aging solutions is on the rise globally, with adults seeking ways to retain their young appearance and the elderly focusing on measures to keep the indications of ageing at check. As a result, this shift in consumer preference is driving the growth of the anti-aging market during the forecast period.
Restraints
High cost of anti-aging treatments
The doctors and healthcare providers treat people with various type of processes and treatments against anti-aging. The anti-aging treatments such as hair restoration, anti-pigmentation, adult acne therapy, breast augmentation, liposuction, and chemical peel are quite expensive in nature. These types of anti-aging treatments use different types of devices such as laser aesthetic devices, microdermabrasion devices, and radio frequency devices. The products used in the treatments are premium in nature. As a result, high cost of anti-aging treatments is hampering the growth of the global anti-aging market over the projection period.
Opportunities
Growing geriatric population
The geriatric population is growing at a rapid pace. This kind of people faces variety of skin problems. Those issues mostly include wrinkles. Therefore, doctors recommend them to use anti-aging creams and lotions. Therefore, there is huge demand for anti-aging products globally. Furthermore, due to technological advancements, the key market players are developing new techniques for the treatment of anti-aging among senior or old people. This factor is creating lucrative opportunities for the expansion of the global anti-aging market.
Challenges
Adverse side effects of anti-aging products
As customers want organic and natural skincare products, the popularity of chemical-based anti-aging and anti-wrinkle treatments is expected to decline. This is due to a number of incidents in which the negative consequences of these items have been revealed. These products may cause reactions ranging from moderate irritation to allergic contact dermatitis in people who are sensitive to them. The high-dose chemical content may raise the risk of skin allergies, limiting sales potential for anti-aging product manufacturers. Thus, adverse side effects of anti-aging products are a biggest challenge for the expansion of the anti-aging market.
Why should you invest in this report?
If you are aiming to enter the global anti-aging market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for anti-aging are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global anti-aging market include:
- Unilever Group
- GALDERMA LABORATORIES L.P.
- Procter & Gamble (P&G) Company
- Nu Skin Enterprises Inc.
- Hologic Inc.
- Pierre Fabre S.A.
- Shiseido Company Limited
- Candela Corporation
- Home Skinovations Ltd.
- Estee Lauder
Market Segmentation:
By Products
- Anti-wrinkle
- Hair color
- Ultraviolet absorption
- Anti-stretch mark
By Treatment
- Hair restoration
- Anti-pigmentation
- Adult acne therapy
- Breast augmentation
- Liposuction
- Chemical peel
By Demography
- Generation X
- Baby Boomers
- Generation Y
- Generation Z
By Devices
- Anti-cellulite treatment
- Laser aesthetic devices
- Microdermabrasion devices
- Radio frequency devices
- Others
By End User
- Hospitals
- Clinics
- Home healthcare
Regional Analysis:
The geographical analysis of the global anti-aging market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global anti-aging Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global anti-aging market in 2030?
- What is the expected CAGR for the anti-aging market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global anti-aging market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Anti-aging Market
5.1. COVID-19 Landscape: Anti-aging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Anti-aging Market, By Products Type
8.1. Anti-aging Market, by Products Type, 2022-2030
8.1.1. Anti-wrinkle
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Hair color
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Ultraviolet absorption
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Anti-stretch mark
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Anti-aging Market, By Treatment Type
9.1. Anti-aging Market, by Treatment Type, 2022-2030
9.1.1. Hair restoration
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Anti-pigmentation
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Adult acne therapy
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Breast augmentation
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Liposuction
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Chemical Peel
9.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Anti-aging Market, By Demography Type
10.1. Anti-aging Market, by Demography Type, 2022-2030
10.1.1. Generation X
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Baby Boomers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Generation Y
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Generation Z
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Anti-aging Market, By Devices Type
11.1. Anti-aging Market, by Devices Type, 2022-2030
11.1.1. Anti-cellulite treatment
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Laser aesthetic devices
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Microdermabrasion devices
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Radio frequency devices
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Anti-aging Market, By End User Type
12.1. Anti-aging Market, by End User, 2022-2030
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Clinics
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Home healthcare
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Anti-aging Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Products (2017-2030)
13.1.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.1.3. Market Revenue and Forecast, by Demography (2017-2030)
13.1.4. Market Revenue and Forecast, by Devices (2017-2030)
13.1.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Products (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Demography (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Devices (2017-2030)
13.1.7. Market Revenue and Forecast, by End User (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Products (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Demography (2017-2030)
13.1.8.4. Market Revenue and Forecast, by Devices (2017-2030)
13.1.8.5. Market Revenue and Forecast, by End User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Products (2017-2030)
13.2.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.2.3. Market Revenue and Forecast, by Demography (2017-2030)
13.2.4. Market Revenue and Forecast, by Devices (2017-2030)
13.2.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Products (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Demography (2017-2030)
13.2.7. Market Revenue and Forecast, by Devices (2017-2030)
13.2.8. Market Revenue and Forecast, by End User (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Products (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Demography (2017-2030)
13.2.10. Market Revenue and Forecast, by Devices (2017-2030)
13.2.11. Market Revenue and Forecast, by End User (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Products (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Demography (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Devices (2017-2030)
13.2.13. Market Revenue and Forecast, by End User (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Products (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Demography (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Devices (2017-2030)
13.2.15. Market Revenue and Forecast, by End User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Products (2017-2030)
13.3.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.3.3. Market Revenue and Forecast, by Demography (2017-2030)
13.3.4. Market Revenue and Forecast, by Devices (2017-2030)
13.3.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Products (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Demography (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Devices (2017-2030)
13.3.7. Market Revenue and Forecast, by End User (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Products (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Demography (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Devices (2017-2030)
13.3.9. Market Revenue and Forecast, by End User (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Products (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Demography (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Devices (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Products (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Demography (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Devices (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Products (2017-2030)
13.4.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.4.3. Market Revenue and Forecast, by Demography (2017-2030)
13.4.4. Market Revenue and Forecast, by Devices (2017-2030)
13.4.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Products (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Demography (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Devices (2017-2030)
13.4.7. Market Revenue and Forecast, by End User (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Products (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Demography (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Devices (2017-2030)
13.4.9. Market Revenue and Forecast, by End User (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Products (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Demography (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Devices (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Products (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Demography (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Devices (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Products (2017-2030)
13.5.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.5.3. Market Revenue and Forecast, by Demography (2017-2030)
13.5.4. Market Revenue and Forecast, by Devices (2017-2030)
13.5.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Products (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Demography (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Devices (2017-2030)
13.5.7. Market Revenue and Forecast, by End User (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Products (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Treatment (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Demography (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Devices (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)
Chapter 14. Company Profiles
14.1. Unilever Group
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. GALDERMA LABORATORIES L.P.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Procter & Gamble (P&G) Company
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Nu Skin Enterprises Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Hologic Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Pierre Fabre S.A.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Shiseido Company Limited
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Candela Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Home Skinovations Ltd.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Estee Lauder
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1597
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments